Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202693
Company: AVET LIFESCIENCES

Products on ANDA 202693

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202693

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/19/2014	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/26/2024	SUPPL-7	Labeling-Package Insert		Label is not available on this site.
07/26/2024	SUPPL-5	Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 202693

ACETAZOLAMIDE SODIUM

INJECTABLE;INJECTION; EQ 500MG BASE/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	202693	AVET LIFESCIENCES
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	040089	HIKMA
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	200880	MYLAN ASI
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	040784	XGEN PHARMS
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	206533	ZYDUS PHARMS